20 Mid-Cap Stocks Insiders Were Buying in Q1 2025

Page 3 of 19

17. Bruker Corporation (NASDAQ:BRKR)

Market Cap: $5.52 billion

Bruker Corporation develops and sells scientific instruments and diagnostic solutions worldwide, operating through four segments: BioSpin, CALID, Nano, and Energy & Supercon Technologies. Its products include tools for magnetic resonance, mass spectrometry, molecular diagnostics, X-ray analysis, atomic force microscopy, and advanced imaging technologies. Founded in 1960, Bruker is headquartered in Billerica, Massachusetts.

In February and March, two insiders, including the company’s CEO, purchased around $1.04 million worth of Bruker shares at an average price of $49.79 per share. Currently, the stock trades at $36.41, having lost 37.89% since the beginning of the year, and 56.09% over the past 12 months.

Bruker Corporation recently launched the nVista 2P, a lightweight two-photon miniscope designed for high-resolution imaging of brain activity in freely moving animals. Weighing just 2 grams, it captures 3D, single-cell resolution images up to 300 microns deep, making it ideal for studying neural circuits in regions like the entorhinal cortex and hypothalamus. The device supports both shallow and deep brain imaging using existing one-photon protocols.

According to MarketBeat, 11 analysts rate Bruker stock as a “Moderate Buy” with an average price target of $66.50.

Bruker is also one of the 7 best medical technology stocks to buy according to analysts.

Page 3 of 19